ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years
Gregory G. Tsiotos
Matched on ORCID iD 0000-0002-8809-9396; OpenAlex author ID A5103341655. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18479-z↗
- Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18212-w↗
- Portal-mesenteric vein resection for pancreatic cancer: Results in par with the defined benchmark outcomes. Co-author DOI 10.3389/fsurg.2022.1069802↗
- Portal-Mesenteric Vein Resection in Borderline Pancreatic Cancer; 33 Month-Survival in Patients with Good Performance Status. Co-author DOI 10.1089/pancan.2019.0013↗
- Individuals at high-risk for pancreatic cancer development: management options and the role of surgery. First author DOI 10.1016/j.suronc.2011.12.006↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Allegra Ripolli · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Kongyuan Wei · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Emanuele F. Kauffmann · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Riccardo Casadei · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Sergio Alfieri · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- V. Egorov · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Alessandro Zerbi · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Yuichi Nagakawa · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Niccolò Napoli · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Benedetto Ielpo · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Elena B. Rangelova · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Emilio Vicente · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Ugo Boggi · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Marc G. Besselink · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Giuseppe Fusai · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Roberto Coppola · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Maria Psomas · 2 shared papers, 2019–2022 · strength 0.23
- Paper Portal-mesenteric vein resection for pancreatic cancer: Results in par with the defined benchmark outcomes. DOI 10.3389/fsurg.2022.1069802↗
- Paper Portal-Mesenteric Vein Resection in Borderline Pancreatic Cancer; 33 Month-Survival in Patients with Good Performance S… DOI 10.1089/pancan.2019.0013↗
- Georgia G Kostopanagiotou · 1 shared paper, 2022 · strength 0.15
- Alexios S Strimpakos · 1 shared paper, 2022 · strength 0.15
- Theodoros P. Michelakos · 1 shared paper, 2019 · strength 0.09
- George H. Sakorafas · 1 shared paper, 2012 · strength 0.04
- Vasileios E. Smyrniotis · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.